VALBIOTIS to begin trial of TOTUM-070 for LDL-cholesterol treatment
VALBIOTIS is set to initiate a Phase II HEART clinical study of TOTUM-070 for the...
GenSight Biologics’ gene therapy proves safe in LHON trial
GenSight Biologics has reported that results from the Phase I/IIa REVEAL clinical trial of LUMEVOQ...
Genkyotex’s setanaxib shows favourable safety profile in Phase I trial
French biopharmaceutical firm Genkyotex has reported positive data from the Phase I trial of its...
Debiopharm begins Phase II trial of alisporivir against Covid-19 in France
Swiss biopharmaceutical firm Debiopharm has started the dosing of the first patient in a Phase...
Acticor Biotech recruits first patient in Covid-19 related ARDS treatment trial
Clinical stage biotechnology company Acticor Biotech has recruited the first patient in Phase II GARDEN...
Valneva begins Phase I/II study of Covid-19 vaccine candidate
France-based specialty vaccine company Valneva has commenced the Phase I/II VLA2001-201 clinical study of its...
Does Arcturus’ one-shot Covid-19 vaccine have the potential to match up with leading BioNTech/Pfizer and Moderna candidates?
Leading COVID-19 vaccine candidates from Pfizer/BioNTech (BNT-162b2) and Moderna (mRNA-1273) currently in Phase III trials...
Kayentis raises funding to accelerate digital platform expansion for trials
Digital data capture technologies provider Kayentis has raised about $8.3m in growth capital in an...
Sanofi and Regeneron report eosinophilic esophagiti trial data
Sanofi and Regeneron Pharmaceuticals have reported additional positive results from Part A of a Phase...
Sanofi and Translate Bio find positive preclinical Covid-19 vaccine results
Sanofi’s vaccines global business unit Sanofi Pasteur and Translate Bio have reported preclinical trial results...